New Sequencing Platforms Drive Choice, Competition, Lawsuits in 2010

While newcomers Pacific Biosciences and Complete Genomics raised considerable funds and went public in 2010, publicly traded Helicos Biosciences continued to reduce its headcount. In the meantime, both Life Technologies and Roche, through acquisitions and partnerships, bolstered their sequencing R&D pipelines with new technologies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.